Immunome, Inc. (IMNM) vs LeMaitre Vascular, Inc. (LMAT)
A side-by-side comparison of Immunome, Inc. and LeMaitre Vascular, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNM
Immunome, Inc.
$19.89HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
LMAT
LeMaitre Vascular, Inc.
$79.47HealthcareDelayed quote: Oct 6, 2026, 2:38 PM EDT
Total return — IMNM vs LMAT
growth of $100 · dividends reinvested · last 6yIMNM +57.4% (+7.9%/yr)LMAT +163.7% (+17.5%/yr)LMAT compounded faster over this window
IMNM LMAT
IMNM vs LMAT: by the numbers
- •IMNM is the larger company ($1.90B vs $1.82B market cap).
- •LMAT is profitable (25.02% net margin) while IMNM runs a net loss (-3059.99%).
- •LMAT pays a dividend (1.17% yield), while IMNM has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | IMNM | LMAT |
|---|---|---|
| P/E ratio | N/A | 27.88 |
| Forward P/E | N/A | 27.66 |
| PEG ratio | N/A | 1.44 |
| P/S ratio | N/A | 6.92 |
| P/B ratio | 3.62 | 4.32 |
| EV / EBITDA | N/A | 21.78 |
| FCF yield | N/A | 4.07% |
Profitability
| Metric | IMNM | LMAT |
|---|---|---|
| Gross margin | 57.43% | 72.90% |
| Operating margin | -3084.76% | 29.46% |
| Net margin | -3059.99% | 25.02% |
| ROE | -48.43% | 15.62% |
| ROIC | -51.06% | 9.81% |
Dividends
| Metric | IMNM | LMAT |
|---|---|---|
| Dividend yield | N/A | 1.17% |
| Payout ratio | N/A | 33.33% |
Growth (annualized)
| Metric | IMNM | LMAT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 11.76% |
| EPS CAGR (5Y) | N/A | 19.42% |
| FCF CAGR (5Y) | N/A | 13.06% |
| Total return CAGR (5Y) | 2.88% | 9.79% |
Frequently asked
- Does IMNM or LMAT pay a bigger dividend?
- LMAT pays a dividend (1.17% yield), while IMNM has no payments in the available dividend history.
- Is IMNM or LMAT more profitable?
- LMAT runs the higher net margin — IMNM at -3059.99% versus LMAT at 25.02%.
- How have IMNM and LMAT total returns compared?
- Over the past 5 years, IMNM delivered 2.88% and LMAT delivered 9.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LeMaitre Vascular P/E ratioLeMaitre Vascular dividend yieldImmunome ROELeMaitre Vascular ROEImmunome operating marginLeMaitre Vascular operating marginImmunome revenue growthLeMaitre Vascular revenue growthImmunome free cash flowLeMaitre Vascular free cash flow
Immunome & LeMaitre Vascular appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.